Leveraging Wearable Technologies for Arrhythmia Detection in Children - The PAW (Pediatric Apple Watch) Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Arrhythmia in Children
- Sponsor
- Stanford University
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Heart rate correlation
- Status
- Enrolling By Invitation
- Last Updated
- last year
Overview
Brief Summary
Specific Aim #1 - To determine the accuracy of Apple Watch ECG tracings heart rate in children.
Specific Aim #2 - To determine if extended monitoring with the Apple Watch can identify arrhythmia events that were not detected by short term clinical monitoring.
Investigators
Scott Ceresnak
Professor of Pediatrics
Stanford University
Eligibility Criteria
Inclusion Criteria
- •All pediatric patients age 6 - 21 years undergoing clinically indicated arrhythmia monitoring
- •Patients with developmental ability (as determined by patient and parents) to safely wear the Apple Watch and utilize the patient activated trigger buttons on both the clinical monitor and the Apple Watch.
Exclusion Criteria
- •Age \< 6 years. Those under 6 many not be able to safely use the watch and have the developmental ability (as gauged by clinician and parents) to utilize the trigger features on the watch and cardiac rhythm monitor.
- •Inability to effectively utilize the triggered features of the monitor or watch
- •Patients unable to utilize the Apple Watch.
Outcomes
Primary Outcomes
Heart rate correlation
Time Frame: Up to 2 weeks
Comparison of heart rate (bpm) between the Apple Watch and standard clinical rhythm monitor
Arrhythmia correlation
Time Frame: Up to 6 months
Comparison of the number of clinically significant arrhythmia events between the Apple Watch and standard clinical rhythm monitor. Clinically significant arrhythmia events include supraventricular arrhythmias, ventricular arrhythmias, sinus pauses, and conduction abnormalities/heart block